AGEN1884

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
RaPiDS- A Phase 2 Study of Anti-PD-1 Independently or in Combination With Anti-CTLA-4 in Second-Line Cervical CancerNCT03894215AGENPhase 2Terminated2025-03-26Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.